Primary Site >> Stomach Cancer
Gene >> TUBB3
| 1. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2007 Oct;60(5):703-11. | ||||||||||
| Title: | Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. | ||||||||||
| Author: | Wei, Jia|Liu, Baorui|Wang, Lifeng|Qian, Xiaoping|Ding, Yitao|Yu, Lixia | ||||||||||
| PMID: | 17256130 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Cancer Ther. 2008 Jan;7(1):233-41. | ||||||||||
| Title: | From plasma membrane to cytoskeleton: a novel function for semaphorin 6A. | ||||||||||
| Author: | Prislei, Silvia|Mozzetti, Simona|Filippetti, Flavia|De Donato, Marta|Raspaglio, Giuseppina|Cicchillitti, Lucia|Scambia, Giovanni|Ferlini, Cristiano | ||||||||||
| PMID: | 18187809 | ||||||||||
| 3. | |||||||||||
| Journal: | Lancet Oncol. 2008 Feb;9(2):168-75. | ||||||||||
| Title: | Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents? | ||||||||||
| Author: | Seve, Pascal|Dumontet, Charles | ||||||||||
| PMID: | 18237851 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncol Rep. 2008 Dec;20(6):1545-51. | ||||||||||
| Title: | Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. | ||||||||||
| Author: | Tsutani, Yasuhiro|Yoshida, Kazuhiro|Sanada, Yuichi|Wada, Yoshiyuki|Konishi, Kazuo|Fukushima, Masakazu|Okada, Morihito | ||||||||||
| PMID: | 19020740 | ||||||||||
| 5. | |||||||||||
| Journal: | Chin J Cancer Res. 2011 Dec;23(4):288-94. | ||||||||||
| Title: | Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III beta-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin. | ||||||||||
| Author: | Lu, Ming|Gao, Jing|Wang, Xi-Cheng|Shen, Lin | ||||||||||
| PMID: | 23358102 | ||||||||||
| 6. | |||||||||||
| Journal: | Med Oncol. 2012 Dec;29(5):3029-34. | ||||||||||
| Title: | Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine. | ||||||||||
| Author: | Yu, Jingwei|Gao, Jing|Lu, Zhihao|Li, Yilin|Shen, Lin | ||||||||||
| PMID: | 22766748 | ||||||||||
| 7. | |||||||||||
| Journal: | BMC Cancer. 2013 Sep 23;13:431. | ||||||||||
| Title: | Class III beta-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer. | ||||||||||
| Author: | Hwang, Jun-Eul|Hong, Ji-Yun|Kim, Karham|Kim, Seung-Hun|Choi, Won-Young|Kim, Min-Jee|Jung, Sung-Hoon|Shim, Hyun-Jeong|Bae, Woo-Kyun|Hwang, Eu-Chang|Lee, Kyung-Hwa|Lee, Jae-Hyuk|Cho, Sang-Hee|Chung, Ik-Joo | ||||||||||
| PMID: | 24053422 | ||||||||||
| 8. | |||||||||||
| Journal: | Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Jun;38(6):582-9. | ||||||||||
| Title: | [Effect of TUBB3, TS and ERCC1 mRNA expression on chemoresponse and clinical outcome of advanced gastric cancer by multiplex branched-DNA liquid chip technology]. | ||||||||||
| Author: | Huang, Jin|Hu, Huabin|Xie, Yangchun|Tang, Youhong|Liu, Wei|Zhong, Meizuo | ||||||||||
| PMID: | 23828702 | ||||||||||
| 9. | |||||||||||
| Journal: | Biomaterials. 2013 Sep;34(29):7191-203. | ||||||||||
| Title: | Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. | ||||||||||
| Author: | Liu, Qin|Li, Ru-Tian|Qian, Han-Qing|Wei, Jia|Xie, Li|Shen, Jie|Yang, Mi|Qian, Xiao-Ping|Yu, Li-Xia|Jiang, Xi-Qun|Liu, Bao-Rui | ||||||||||
| PMID: | 23806972 | ||||||||||
| 10. | |||||||||||
| Journal: | Yonsei Med J. 2013 Mar 1;54(2):374-80. | ||||||||||
| Title: | Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells. | ||||||||||
| Author: | Hwang, Jun-Eul|Lee, Ji-Hee|Park, Mi-Ra|Kim, Dae-Eun|Bae, Woo-Kyun|Shim, Hyun-Jeong|Cho, Sang-Hee|Chung, Ik-Joo | ||||||||||
| PMID: | 23364970 | ||||||||||
| 11. | |||||||||||
| Journal: | Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Feb;34(2):224-9. | ||||||||||
| Title: | [Synergistic interaction between melittin and chemotherapeutic agents and their possible mechanisms: an experimental research]. | ||||||||||
| Author: | Wang, Rui-Ping|Huang, Shu-Ran|Zhou, Jin-Yong|Zou, Xi | ||||||||||
| PMID: | 24672950 | ||||||||||
| 12. | |||||||||||
| Journal: | Eur J Cancer. 2014 Sep;50(13):2328-35. | ||||||||||
| Title: | Combination of microtubule associated protein-tau and beta-tubulin III predicts chemosensitivity of paclitaxel in patients with advanced gastric cancer. | ||||||||||
| Author: | Yu, Jingwei|Gao, Jing|Lu, Zhihao|Gong, Jifang|Li, Yanyan|Dong, Bin|Li, Zhongwu|Zhang, Xiaotian|Shen, Lin | ||||||||||
| PMID: | 25016949 | ||||||||||
| 13. | |||||||||||
| Journal: | Eur J Med Res. 2014 Sep 16;19:50. | ||||||||||
| Title: | Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients. | ||||||||||
| Author: | Luo, Yushuang|Li, Zhanquan|Cui, Sen|Shen, Cunfang|Zhao, Junhui|Wu, Milu|Li, Yuying|Wang, Miaozhou|Chen, Rong|Liu, Zhibo|Ri-Li, Ge | ||||||||||
| PMID: | 25223338 | ||||||||||
| 14. | |||||||||||
| Journal: | Evid Based Complement Alternat Med. 2015;2015:390812. | ||||||||||
| Title: | Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells. | ||||||||||
| Author: | Li, Wei-Bing|Li, Yang|Yu, Chen|He, Yong-Ming | ||||||||||
| PMID: | 25705237 | ||||||||||
| 15. | |||||||||||
| Journal: | Eur J Med Res. 2015 Mar 26;20:29. | ||||||||||
| Title: | Retraction note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients. | ||||||||||
| Author: | |||||||||||
| PMID: | 25888862 | ||||||||||
| 16. | |||||||||||
| Journal: | Am J Transl Res. 2015 Aug 15;7(8):1429-39. eCollection 2015. | ||||||||||
| Title: | Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes. | ||||||||||
| Author: | Li, Shu-Chun|Ma, Rong|Wu, Jian-Zhong|Xiao, Xia|Wu, Wei|Li, Gang|Chen, Bo|Sharma, Ashok|Bai, Shan|Dun, Bo-Ying|She, Jin-Xiong|Tang, Jin-Hai | ||||||||||
| PMID: | 26396673 | ||||||||||
| 17. | |||||||||||
| Journal: | Am J Transl Res. 2016 Dec 15;8(12):5729-5740. eCollection 2016. | ||||||||||
| Title: | Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. | ||||||||||
| Author: | Wu, Jianzhong|Li, Shuchun|Ma, Rong|Sharma, Ashok|Bai, Shan|Dun, Boying|Cao, Haixia|Jing, Changwen|She, Jinxiong|Feng, Jifeng | ||||||||||
| PMID: | 28078044 | ||||||||||
| 18. | |||||||||||
| Journal: | BMC Gastroenterol. 2017 Jan 5;17(1):2. | ||||||||||
| Title: | Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. | ||||||||||
| Author: | Cao, Yongkuan|Zhang, Guohu|Wang, Peihong|Zhou, Jun|Gan, Wei|Song, Yaning|Huang, Ling|Zhang, Ya|Luo, Guode|Gong, Jiaqing|Zhang, Lin | ||||||||||
| PMID: | 28056823 | ||||||||||
| 19. | |||||||||||
| Journal: | Cancer Biomark. 2018 Feb 6;21(2):439-447. | ||||||||||
| Title: | Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer. | ||||||||||
| Author: | Wang, Yang-Kun|Wang, Su-Nan|Li, Ying-Ying|Wang, Gong-Ping|Yun, Tian|Zhu, Chao-Ya|Yang, Bin-Feng|Li, Cong-Yang|Jiang, Bo|Zhu, Mei-Ling | ||||||||||
| PMID: | 29125480 | ||||||||||